MAKI NISHIO

2.8k total citations
83 papers, 2.2k citations indexed

About

MAKI NISHIO is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, MAKI NISHIO has authored 83 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 31 papers in Pharmacology and 18 papers in Oncology. Recurrent topics in MAKI NISHIO's work include Microbial Natural Products and Biosynthesis (28 papers), Fungal Biology and Applications (16 papers) and Peptidase Inhibition and Analysis (11 papers). MAKI NISHIO is often cited by papers focused on Microbial Natural Products and Biosynthesis (28 papers), Fungal Biology and Applications (16 papers) and Peptidase Inhibition and Analysis (11 papers). MAKI NISHIO collaborates with scholars based in Japan, United States and Germany. MAKI NISHIO's co-authors include Saburo Komatsubara, Jun Kohno, Tetsuo Ohnuki, TOSHIKAZU OKI, Tôru Okuda, Yutaka Koguchi, MASATAKA KONISHI, Takeo Miyaki, Kimio Kawano and KYOICHIRO SAITOH and has published in prestigious journals such as Optics Letters, The Journal of Organic Chemistry and Annals of Oncology.

In The Last Decade

MAKI NISHIO

76 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MAKI NISHIO Japan 27 1.0k 822 612 233 213 83 2.2k
Susanne Grabley Germany 33 1.3k 1.3× 1.1k 1.4× 995 1.6× 225 1.0× 529 2.5× 108 3.0k
Birendra N. Pramanik United States 26 1.2k 1.2× 603 0.7× 382 0.6× 157 0.7× 206 1.0× 112 2.6k
Marshall M. Siegel United States 32 1.5k 1.5× 1.0k 1.3× 558 0.9× 244 1.0× 134 0.6× 82 3.1k
Hye‐Sook Kim Japan 31 1.0k 1.0× 1.2k 1.5× 327 0.5× 167 0.7× 72 0.3× 110 2.6k
Christoph Tamm Switzerland 28 1.6k 1.6× 1.2k 1.5× 744 1.2× 142 0.6× 306 1.4× 165 3.0k
Andrew M. Gulick United States 37 3.3k 3.2× 394 0.5× 1.5k 2.4× 187 0.8× 304 1.4× 93 4.3k
Tomoyasu Hirose Japan 29 948 0.9× 1.3k 1.5× 641 1.0× 205 0.9× 306 1.4× 138 2.4k
Satoshi Ichikawa Japan 32 2.0k 1.9× 1.8k 2.2× 610 1.0× 167 0.7× 197 0.9× 155 3.3k
Anna Roujeinikova Australia 27 1.5k 1.5× 398 0.5× 194 0.3× 92 0.4× 113 0.5× 79 2.6k
Georg Zocher Germany 25 1.3k 1.3× 246 0.3× 635 1.0× 120 0.5× 129 0.6× 44 2.0k

Countries citing papers authored by MAKI NISHIO

Since Specialization
Citations

This map shows the geographic impact of MAKI NISHIO's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MAKI NISHIO with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MAKI NISHIO more than expected).

Fields of papers citing papers by MAKI NISHIO

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MAKI NISHIO. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MAKI NISHIO. The network helps show where MAKI NISHIO may publish in the future.

Co-authorship network of co-authors of MAKI NISHIO

This figure shows the co-authorship network connecting the top 25 collaborators of MAKI NISHIO. A scholar is included among the top collaborators of MAKI NISHIO based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MAKI NISHIO. MAKI NISHIO is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tahara, Kohei, MAKI NISHIO, & Hirofumi Takeuchi. (2017). Evaluation of liposomal behavior in the gastrointestinal tract after oral administration using real-time in vivo imaging. Drug Development and Industrial Pharmacy. 44(4). 608–614. 27 indexed citations
2.
Sunami, Kuniko, Yoshiro Nakahara, Satoru Kitazono, et al.. (2017). Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma. Annals of Oncology. 28. v571–v572.
3.
NISHIO, MAKI, Takashi Takahashi, Atsushi Horiike, et al.. (2013). A Feasibility Study of Carboplatin Plus Irinotecan Treatment for Elderly Patients with Extensive Disease Small-cell Lung Cancer. Japanese Journal of Clinical Oncology. 44(2). 116–121. 6 indexed citations
4.
Horai, Takeshi, Ikuo Sekine, Nobuyuki Yamamoto, et al.. (2011). Safety of BLP25 Liposome Vaccine (L-BLP25) in Japanese Patients with Unresectable Stage III NSCLC after Primary Chemoradiotherapy: Preliminary Results from a Phase I/II Study. Japanese Journal of Clinical Oncology. 41(5). 718–722. 36 indexed citations
5.
Sakurai, Masaaki, et al.. (2003). TMC-264, a Novel Inhibitor of STAT6 Activation Produced by Phoma sp. TC 1674. The Journal of Antibiotics. 56(6). 513–519. 30 indexed citations
6.
NISHIO, MAKI, et al.. (2000). TMC-135A and B, New Triene-ansamycins, Produced by Streptomyces sp.. The Journal of Antibiotics. 53(7). 724–727. 21 indexed citations
7.
Koguchi, Yutaka, MAKI NISHIO, Shinichi Suzuki, et al.. (2000). TMC-89A and B, New Proteasome Inhibitors from Streptomyces sp. TC 1087.. The Journal of Antibiotics. 53(9). 967–972. 18 indexed citations
8.
Asai, Yasuyuki, MAKI NISHIO, Hideaki Shima, et al.. (1999). TMC-66, a New Endothelin Converting Enzyme Inhibitor Produced by Streptomyces sp. A5008.. The Journal of Antibiotics. 52(7). 607–612. 14 indexed citations
9.
Kohno, Jun, Masaaki Sakurai, Noriaki Kameda, et al.. (1999). Production, Isolation and Biological Properties of TMC-120A, B and C, Novel Inhibitors of Eosinophil Survival from Aspergillus ustus TC 1118.. The Journal of Antibiotics. 52(10). 913–916. 22 indexed citations
10.
11.
Kohno, Jun, Takuya Kawahata, Toru Otake, et al.. (1996). Boromycin, an Anti-HIV Antibiotic. Bioscience Biotechnology and Biochemistry. 60(6). 1036–1037. 61 indexed citations
12.
NISHIO, MAKI, HIROAKI OHKUMA, Masatoshi Kakushima, et al.. (1993). Synthesis and antifungal activities of pradimicin A derivatives modification of the alanine moiety.. The Journal of Antibiotics. 46(3). 494–499. 7 indexed citations
13.
Kamachi, Hajime, et al.. (1993). Synthesis and antifungal activity of pradimicin derivatives. Modifications on the aglycone part.. The Journal of Antibiotics. 46(9). 1447–1457. 12 indexed citations
14.
Ueki, Tomokazu, Kei-Ichi Numata, YOSUKE SAWADA, et al.. (1993). Studies on the mode of antifungal action of pradimicin antibiotics. II. D-mannopyranoside-binding site and calcium-binding site.. The Journal of Antibiotics. 46(3). 455–464. 42 indexed citations
15.
SAWADA, YOSUKE, Takashi Tsuno, Haruaki Yamamoto, et al.. (1990). Pradimicins M, N, O and P, new dihydrobenzo(a)naphthacenequinones produced by blocked mutants of Actinomadura hibisca P157-2.. The Journal of Antibiotics. 43(11). 1367–1374. 13 indexed citations
16.
Azuma, H., S. A. Ramsden, S. J. Rose, et al.. (1990). Short-pulse pumping of a recombination Balmer-α laser of hydrogenic sodium. Optics Letters. 15(18). 1011–1011. 13 indexed citations
17.
Fujiwara, M., et al.. (1990). A coherent photonic wavelength-division switching system for broad-band networks. Journal of Lightwave Technology. 8(3). 416–422. 6 indexed citations
18.
SAWADA, YOSUKE, MAKI NISHIO, Haruaki Yamamoto, et al.. (1990). New antifungal antibiotics, pradimicins D and E. Glycine analogs of pradimicins A and C.. The Journal of Antibiotics. 43(7). 771–777. 32 indexed citations
19.
TSUNAKAWA, MITSUAKI, MAKI NISHIO, HIROAKI OHKUMA, et al.. (1989). The structure of pradimicins A, B and C: a novel family of antifungal antibiotics. The Journal of Organic Chemistry. 54(11). 2532–2536. 61 indexed citations
20.
Ito, Tatsuro, MAKI NISHIO, & Hiroshi Ogawa. (1964). THE STRUCTURE OF KANAMYCIN B.. PubMed. 17. 189–93. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne Grabley Breakdown of academic impact, for papers by Birendra N. Pramanik Breakdown of academic impact, for papers by Marshall M. Siegel Breakdown of academic impact, for papers by Hye‐Sook Kim Breakdown of academic impact, for papers by Christoph Tamm Breakdown of academic impact, for papers by Andrew M. Gulick Breakdown of academic impact, for papers by Tomoyasu Hirose Breakdown of academic impact, for papers by Satoshi Ichikawa Breakdown of academic impact, for papers by Anna Roujeinikova Breakdown of academic impact, for papers by Georg Zocher
Rankless by CCL
2026